Hepatocyte TrkB Acts as a Gatekeeper Against MASH ‐Related Liver Fibrosis by Suppressing the TGFβ / CCL2 Axis and Macrophage Infiltration
Cell Proliferation · 2026-08 · 59 (8)
DOI: 10.1111/cpr.70202 ↗At a glance
Journal article in Cell Proliferation, published online on 2026-04-03. Written by Yueying Chen and 11 co-authors. Institution: Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China. Major MEDLINE topics: Macrophages, Liver Cirrhosis, Transforming Growth Factor beta, Chemokine CCL2. Cited 1 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science Foundation of China, Shanghai Science and Technology Committee, National Natural Science Foundation of China.
Abstract (original language)
Liver fibrosis represents a critical pathological stage in chronic liver disease, characterized by excessive activation of hepatic stellate cells ( HSCs ) and dysregulated immune cell recruitment. Our previous studies demonstrated that overexpressing tyrosine kinase receptor B ( TrkB ) in HSCs inhibits their activation, thereby alleviating liver fibrosis. However, its functional significance in hepatocytes—the predominant parenchymal cells orchestrating liver homeostasis—remains poorly understood. Here, we investigate the mechanistic interplay between hepatocyte‐specific TrkB signalling and liver fibrosis progression. Through integrated in vivo animal models and in vitro two‐ and three‐dimensional systems, we demonstrate that elevated TrkB expression in hepatocytes reduces pro‐fibrotic and inflammatory cytokines, attenuates HSC activation via paracrine signalling, and impairs monocyte‐derived macrophage ( MoMF ) recruitment. Mechanistically, TrkB modulates the TGFβ / SMAD3 pathway by inhibiting p‐ SMAD3 nuclear translocation, thus suppressing FOS transcription. As a core component of the AP ‐1 transcription factor complex, FOS directly regulates CCL2 , a pivotal chemokine for macrophage recruitment. Collectively, these results establish TrkB as a key regulatory node in the TGFβ / SMAD3 / FOS / CCL2 signalling cascade, orchestrating macrophage‐mediated fibrotic responses in the liver.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Shanghai Institute of Liver Diseases, Shanghai, China.
- Department of Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Gastroenterology, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
- Joint Laboratory of Biomaterials and Translational Medicine, Puheng Biomedicine Co., Ltd, Shanghai, China.
- Chinese Medicine Guangdong Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese M…
ORCID profiles: Heming Wang, Yicheng Zhao, Changfeng Zhu, Ling Dong
Funding
- National Science Foundation of China
- Shanghai Science and Technology Committee
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Cite
APA
Chen, Y., Wei, J., Li, S., Yin, K., Wang, H., Zhao, Y., Weng, S., Shen, X., Song, G., Zhu, C., Yao, Q., & Dong, L. (2026). Hepatocyte TrkB Acts as a Gatekeeper Against MASH ‐Related Liver Fibrosis by Suppressing the TGFβ / CCL2 Axis and Macrophage Infiltration. Cell Proliferation, 59(8). https://doi.org/10.1111/cpr.70202
Vancouver
Chen Y, Wei J, Li S, Yin K, Wang H, Zhao Y, et al. Hepatocyte TrkB Acts as a Gatekeeper Against MASH ‐Related Liver Fibrosis by Suppressing the TGFβ / CCL2 Axis and Macrophage Infiltration. Cell Proliferation. 2026;59(8). doi:10.1111/cpr.70202
BibTeX
@article{Chen2026,
author = {Chen, Yueying and Wei, Jiayi and Li, Shuxuan and Yin, Kefan and Wang, Heming and Zhao, Yicheng and Weng, Shuqiang and Shen, Xizhong and Song, Guangqi and Zhu, Changfeng and Yao, Qunyan and Dong, Ling},
title = {Hepatocyte TrkB Acts as a Gatekeeper Against MASH ‐Related Liver Fibrosis by Suppressing the TGFβ / CCL2 Axis and Macrophage Infiltration},
journal = {Cell Proliferation},
year = {2026},
volume = {59},
number = {8},
doi = {10.1111/cpr.70202}
}
EUVIMED